CIRM board approved three projects targeting COVID-19
On May 29, 2020, the California Institute for Regenerative Medicine (CIRM) approved investments in three early-stage research programs…
-
-
Moderna announced first participants in each age cohort dosed in phase 2 study of mRNA vaccine against novel Coronavirus
On May 29, 2020, Moderna announced the first participants in each age cohort had been dosed in the…
-
Johnson & Johnson received positive CHMP opinion for Janssen’s investigational preventive Ebola vaccine regimen
On May 29, 2020, Johnson & Johnson announced that its Janssen Pharmaceutical subsidiary received a positive opinion from…
-
The US Dept of Defense launched effort to collect COVID-19 convalescent plasma
On May 29, 2020, U.S. Department of Defense (DoD) announced it had begun an effort to collect 8,000…
-
The US Dept of Veterans Affairs conducted deep-dive study into effects of COVID-19 on Veterans
On May 28, 2020, the U.S. Dept. of Veterans Affairs (VA) began a national four-year study on the…
-
Vaxxas announced that Merck exercised option to apply novel immune system activation platform for Vaccine candidate
On May 28, 2020, Vaxxas announced that Merck had exercised its option to utilize Vaxxas’ proprietary High Density…
-
FDA authorized Quest Diagnostics COVID-19 Nasal Specimen Self-Collection Kit for emergency use
On May 28, 2020, Quest Diagnostics announced it had received emergency use authorization (EUA) from the U.S. Food…
-
Roche initiated phase III clinical trial of Actemra/RoActemra plus remdesivir in hospitalised patients with severe COVID-19 pneumonia
On May 28, 2020, Roche announced it had initiated of a global phase III, randomised, double-blind, multicentre study…
-
Atossa Therapeutics announced second COVID-19 therapeutic development program, AT-301 nasal spray
On May 28, 2020, Atossa Therapeutics announced that it had begun the development of a second COVID-19 program…
-
Novavax expanded large-scale global manufacturing capacity
On May 27, 2020, Novavax announced the acquisition of Praha Vaccines, part of the Cyrus Poonawalla Group, in…
-
Quest Diagnostics launched COVID-19 workforce testing services to help organizations in fostering safer workplaces
On May 27, 2020, Quest Diagnostics launched a new suite of Return to Work services built around large-scale…
-
IAVI and Merck announced collaboration to develop vaccine against SARS-CoV-2
On May 26, 2020, Merck and and IAVI, a nonprofit scientific research organization dedicated to addressing urgent, unmet…
-
The FDA approved only drug in U.S. to treat severe malaria
On May 26, 2020, the U.S. Food and Drug Administration (FDA) announced it had approved Amivas’ artesunate for…
-
Philips launched next generation wearable biosensor for early patient deterioration detection for COVID-19
On May 26, 2020, Royal Philips announced it had received 510(k) clearance from the FDA for its wearable…
-
GenScript announced CE-IVD for neutralizing antibody test kit of SARS-CoV-2 and COVID-19 diagnostics
On May 26, 2020, GenScript Biotech announced that it had obtained CE-IVD for its SARS-CoV-2 diagnostic products to…
-
Dementia gene raises risk of severe COVID-19
On May 26, 2020, researchers at the University of Exeter Medical School and the UConn School of Medicine…
-
Merck and Ridgeback Bio announced collaboration to advance development of novel antiviral candidate, EIDD-2801
On May 26, 2020, Merck and and and Ridgeback Biotherapeutics announced a collaboration agreement to develop EIDD-2801, an…
-
Innovation Pharma receives data from public health research institute showing brilacidin inhibits SARS-CoV-2 (COVID-19) in human cell line
On May 26, 2020, Innovation Pharma reported receiving data from a leading public health research institute showing Brilacidin…
-
Cerecor and Myriad Genetics announced levels of novel cytokine, LIGHT highly correlated with disease severity and mortality in COVID-19 ARDS biomarker study
Cerecor and Myriad Genetics announced that levels of novel cytokine, LIGHT, were highly correlated with disease severity and…
-
Novavax initiated phase 1/2 clinical trial of COVID-19 vaccine
On May 26, 2020, Novavax announced enrollment of the first participants in a Phase 1/2 clinical trial of…
-
The FDA approved only drug in the U.S. to treat severe malaria
On May 26, 2020, the U.S. Food and Drug Administration (FDA) approved artesunate for injection to treat severe…
-
Montefiore and Einstein tested new drug combination to conquer COVID-19
On May 26, 2020, Montefiore Health System and Albert Einstein College of Medicine announced they have begun the…
-
Meridian Bioscience supply reagents for manufacturing of tens of millions of COVID-19 antibody tests per month
On May 26, 2020, Meridian Bioscience announced that its SARS-CoV-2 antigens and related reagents are part of assays…
-
Rice University COVID-19 research fund awarded final grants
On May 26, 2020, the Rice University COVID-19 Research Fund Oversight and Review Committee announced it had awarded…
-
OraSures OMNIgene-ORAL kit included in EUA granted to P23 labs for at-home collection of saliva samples for SARS-CoV-2 test
On May 22, 2020, OraSure Technologies announced that its OMNIgene-ORAL saliva collection device (OM-505) was included in the…
-
Biotechnology | COVID-19 | Disease | Infectious Disease | Measles | Polio | Therapeutics | Vaccine | WHO
At least 80 million children under one at risk of diseases such as diphtheria, measles and polio as COVID-19 disrupted routine vaccination efforts
On May 22, 2020, COVID 19 disrupted life-saving immunization services around the world, putting millions of children –…
-
Sinovac secured $15 million in funding to accelerate COVID-19 vaccine development
On May 22, 2020, Sinovac Biotech announced a transaction in which Advantech Capital and Vivo Capital have invested…
-
Analysis of COVID-19 genomes revealed large numbers of introductions to the UK in March, 2020
On May 22, 2020, data reports, published by the COVID-19 Genomics UK Consortium (COG-UK), showed the value in…
-
CIRM board expanded efforts of COVID-19 program
On May 22, 2020, the California Institute for Regenerative Medicine (CIRM) board expanded efforts related to the $5…
-
Abbott announced contract to supply millions of IgG lab-based antibody tests to UK government
On May 21, 2020, Abbott announced a government contract to supply millions of its laboratory-based IgG antibody tests…
